R
Rosa Resino
Researcher at Complutense University of Madrid
Publications - 15
Citations - 411
Rosa Resino is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Viral load & Odds ratio. The author has an hindex of 10, co-authored 14 publications receiving 381 citations. Previous affiliations of Rosa Resino include Hospital General Universitario Gregorio Marañón.
Papers
More filters
Journal ArticleDOI
Impact on weight and height with the use of HAART in HIV-infected children.
TL;DR: HIV-infected children experienced a continued catch-up in weight and height 5 years after starting HAART, and virologic control is related to sustained growth.
Journal ArticleDOI
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Salvador Resino,Rosa Resino,Dariela Micheloud,Dolores Gurbindo-Gutierrez,Juan Antonio León,José Tomás Ramos,Luis Ciria,Isabel de José,José Mellado,Angeles Muñoz-Fernández +9 more
TL;DR: Long-term HAART allowed for restoration of CD4+ cell counts and control of viral loads in HIV-1-infected children, however, initiating HAART after severe immunosuppression has occurred is detrimental for the restoration of the CD4- cell count.
Journal ArticleDOI
Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.
Salvador Resino,Rosa Resino,José María Bellón,Dariela Micheloud,Maria Dolores Gurbindo Gutierrez,María Isabel de José,José Tomás Ramos,Pablo Martín Fontelos,Luis Ciria,María Ángeles Muñoz-Fernández +9 more
TL;DR: It is observed that HAART produces a decrease in adverse clinical outcomes (i.e., hospital admission, AIDS, and death) in children with vertical HIV-1 infection in Madrid, Spain.
Journal ArticleDOI
Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children.
Salvador Resino,José Ma Bellón,Rosa Resino,M. Navarro,José Tomás Ramos,Ma Isabel De José,Mellado Mj,Mª ángeles Muñoz-Fernáendez +7 more
TL;DR: HAART is effective at the population level at decreasing VL, increasing CD4+ T cells, and increasing the survival in a higher percentage of HIV-infected children.
Journal ArticleDOI
Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.
TL;DR: An apparent seasonal variation in hospital admissions of HIV-infected patients with a PTB diagnosis (summer/autumn vs. winter/spring), as well as a link to short-term exposure to environmental risk factors, such as temperature and ambient NO2 and SO2 are suggested.